COMP-MUC1 Salt Bridge Drives Prostate Cancer Bone Metastasis via Ferroptosis Resistance
Researchers found that COMP interacts directly with MUC1 to confer ferroptosis resistance and drive prostate cancer bone metastasis.
Researchers found that COMP interacts directly with MUC1 to confer ferroptosis resistance and drive prostate cancer bone metastasis.
An international study of 1758 men with non-metastatic prostate cancer found that pre-radiotherapy fatigue and diabetes were the strongest predictors ...
Researchers developed PL051, a syngeneic mouse prostate cancer cell line that is androgen-dependent, metastatic and immunocompetent, enabling tests of combined ...
A GLOBOCAN 2022 analysis of 185 countries shows that lifetime risk of penile, prostate, and testicular cancers is highest in ...
A scientific review details the clinical momentum, biological complexity, and dosimetric challenges shaping the next era of precision radiopharmaceutical cancer ...
A meta-analysis of fourteen observational studies found no statistically significant difference in prostate cancer risk between men with high and ...
A retrospective cohort of 97 prostatectomy patients in Jordan found clinical and pathological T staging agreed in only 61.9 percent ...
A retrospective single-center study of 76 prostate cancer patients found that raising the injected activity of Lu-PSMA-I&T from 7.4 to ...
A systematic review of sixteen studies finds that emerging serum and urine protein biomarkers, including PHI, PSP94/PSA ratio, ANXA3 and ...
An optimized SNEDDS formulation of flutamide achieved rapid self-emulsification, near-complete drug release, and stronger cytotoxicity against PC-3 prostate cancer cells ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine